WHO listed 10 countries to have the highest numbers of people with DM in 2000 and 2030. According to this report, Bangladesh has 3.2 million of diabetic subjects in 2000 and the number is expected to increase to a staggering 11.1 million by 2030 placing her among the top 10 countries with DM. 5 In a study Rahim showed a significant increase in the prevalence of DM in rural Bangladesh from 2.3% to 6.8% over 5 years. 6 In another study Akter showed the prevalence of DM in the rural population of Bangladesh is 7.2%. 7 DM is associated with an increased risk of cardiovascular morbidity and mortality, therefore as the prevalence of DM increases there will also be a corresponding increase in morbidity and mortality from cardiovascular disease. 8 The incidence of DM in patients hospitalized with myocardial infarction ranges between 10-20% and approximately 40% have impaired glucose levels. 9, 10 Patients with DM and myocardial infarction have greater incidence of major adverse cardiovascular events, higher in-hospital and long term mortality. 9 Diabetic patients have a higher prevalence of coronary heart disease with an increased number of fatal coronary events due to a higher incidence of plaque rupture and superimposed thrombosis in diffusely diseased coronary arteries. Diabetic patients develop complications more frequently after myocardial infarction (MI) and have double the in-hospital and six-month mortality compared to non-diabetic patients. 11 The primary outcome of ACCORD (MI, stroke, or cardiovascular death) was lower in the intensive glycemic control group, due to a reduction in nonfatal MI, but this reduction was not statistically significant when the study was terminated. 12 Diabetes Control and Complications Trial (DCCT) had shown that, improved glycaemic control in type 1 DM is associated with a sustained decrease in microvascular, macrovascular and neuropathic complications. HbA 1C is a widely used marker of chronic glycemia, reflecting average blood glucose levels over a 2-to 3-month period of time. 13 International Expert Committee, after an extensive review of both established and emerging epidemiological evidence, recommended the use of the HbA 1C test to diagnose DM, with a threshold of <6.5%, and American Diabetic Association affirms this decision. 14 The UKPDS-35 demonstrated that each 1% reduction in haemoglobin HbA 1C was associated with a 14% decrease in risk for MI. 15 Gensini suggested a scoring system which allocates a numerical value for the degree of stenosis in a coronary artery and a multiplication factor that depends on which coronary artery is involved and where the stenosis is located in the coronary artery. This provides a detailed assessment of coronary artery disease and does not ignore even very trivial lesions in coronary arteries. 16 Among diabetic patients there was a positive significant correlation between Gensini score and HbA 1C . Poor control of DM, as measured by a raised percentage of HbA 1C , was found to be an independent predictor of severity of coronary artery disease. 17 There was no study in our country regarding the association of the label of HbA 1C with the severity of coronary artery disease in NSTEMI.
Methods:
This Cross sectional, analytical study conducted in the department of Cardiology, National Heart Foundation Hospital & Research Institute, from June, 2011 to July, 2012. Objective of the study was to find out the association of HbA 1c with severity of IHD in NSTEMI Diabetic patients. Total 104 NSTEMI Diabetic patients were selected purposively. They were divided into two groups according to the level of HbA1c. Group-I patients having HbA1c <7% and group -II patients having HbA1c e"7% . The study protocol was approved by the ethical review board.
Angiographic pattern and severity of CAD:
After all routine investigation coronary angiogram was done during same hospital stay. Interpretations of coronary angiogram were done by visual estimation by two cardiologists to assess the severity of coronary artery disease. Severity of coronary stenosis was graded according to Vessel score and Gensini score.
A. Vessel score 18 : This is the number of vessels with a significant stenosis (for left main coronary artery 50% or greater and for others 70% or greater reduction in luminal diameter). Score ranges from 0 to 3, depending on the number of vessel involve. Left main coronary artery will be scored as single vessel disease.
Score 0 = no vessel involvement. Score 1 = single vessel involvement. Score 2 = double vessel involvement. Score 3 = triple vessel involvement B. Gensini score (Gensini, 1983) 16 : It grades narrowing of the lumen of the coronary artery and scores it as-1 for 1-25% narrowing, 2 for 26-50% narrowing, 4 for 51-75%, 8 for 76-90%, 16 for 91-99% and 32 -completely occluded artery.
This score is then multiplied by a factor according to the importance of the coronary artery. The multiplication factor for a left main stem (LMS) lesion is 5, it is 2.5 for proximal left anterior descending artery (LAD) and proximal circumflex artery (CX) lesions, 1.5 for a mid-LAD lesion, and 1 for distal LAD, mid / distal CX and right coronary artery lesions. The multiplication factor for any other branch is 0.5. Severity of the coronary artery disease was studied by Gensini scoring system.
Statistical Methods:
Data obtained from the study were analyzed and significance of differences was estimated by using statistical methods. Variables were analyzed by chisquare test, t-test, Mann Whitney test where applicable. Correlations were done by Pearson's correlation and Spearman's correlation where applicable. Multiple Linear regression analysis was done. P value <0.05 were considered as significant. Statistical analyses were performed with SPSS, version 17.0 (SPSS Inc). Female patients are small in number in every group. In total sample, 88.5% male and 11.5% female. In Group-I, 84.6% male and 15.4% female. In Grouop-II, 92.3% male and 11.5% female. There was no statistically significant difference between groups in terms of sex distribution (p>0.05). respectively. There was no statistically significant difference between groups in terms of risk factor distribution (p>0.05). Single vessel coronary artery disease was significantly higher in Group-I compared to Group-II. Double vessel coronary artery disease was higher in Group-II compared to Group-I but not statistically significant. Triple vessel coronary artery disease was significantly higher in Group-II compared to Group-I. Similar result was also shown in the work of Saleem. 17 In our study mean Vessel score was significantly higher in Group-II compared to Group-I. Mean Gensini score was significantly higher in group-II compared to group-I. Similar result was also shown in the work of Saleem. 17 In this study, we demonstrated significantly positive linear correlation between HbA 1C level and Vessel score, HbA 1C level and Gensini score. Similar result was also shown in the work of Saleem. 17 In a multiple linear regression model was developed, it clearly showed that HbA 1C was an independent factor influencing the severity of coronary artery disease. Similar result was also shown in the work of Saleem. 17
Results:

Conclusion:
From this study it may be concluded that the presence of HbA1c >7% is associated with severe coronary artery disease with multi vessel involvement in NSTEMI diabetic patients.
